Skip to main content
Clinical Trials/CTRI/2023/06/054125
CTRI/2023/06/054125
Recruiting
Phase 4

Comparison between transtracheal and intravenous 2% lignocaine in attenuating hemodynamic stress response following direct laryngoscopy and endotracheal intubation - NI

Dr Monotosh Pramanik0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: R098- Other specified symptoms and signsinvolving the circulatory and respiratory systems
Sponsor
Dr Monotosh Pramanik
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Monotosh Pramanik

Eligibility Criteria

Inclusion Criteria

  • a)American Society of Anesthesiologists (ASA) I\-II patients
  • b)Aged between 18–60 years of both sexes
  • c)Elective surgical cases under general anesthesia who will require direct laryngoscopy and endotracheal intubation
  • d)Mallampati score I \& II
  • e)Single\-attempt oral intubation

Exclusion Criteria

  • a)Patient refusal and patients who are unable to give valid consent
  • b)Pregnant patients
  • c)Known hypersensitivity to lignocaine
  • d)Anticipated difficult airway
  • e)Video laryngoscope\-assisted intubation
  • f)Patients with restricted neck mobility

Outcomes

Primary Outcomes

Not specified

Similar Trials